Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Houston › NPI 1205502820
Lab

Comprehensive Labs LLC

Comprehensive Labs LLC was paid $1.69M by Medicaid between Apr 2022 and May 2023, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

33Billing provider infoCOMPREHENSIVE LABS LLC
HOUSTON, TX 77079
33aNPI1205502820assigned 08/23/2021
28Total paid$1.69M
24GClaims56,338
24DCodes billed4
24AFirst – last monthApr 2022 – May 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#51 of 436
Median peer was paid$17K
This provider vs. median98×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202252,240$1.56M
20234,098$139K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 74% 23,799 10,756 $1.25M
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 15% 20,260 8,534 $248K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 11% 12,184 6,541 $193K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 95 95 $2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWEAVER, MICKEY (OWNER)